Addiction Medicine 2020
Conference Rewind
We know not everyone can make our popular Addiction Medicine Conferences, so we’re bringing them to you! We’re making these highly-reviewed courses from leading experts in the field accessible all year round. For just $50, you can attend six virtual courses – anywhere, anytime – and earn 4.5 CME.
- Cogitative Traits 1
- Participants will develop an understanding of the risk factors for addiction.
- Participants will be able to understand the neurobiology and cognitive aspects of addiction.
- Participants will have an awareness of evidence-based approaches to the treatment of addiction based on these behavioral and cognitive variables.
- Alcohol Use Disorders 1
- Define AUDs as a spectrum of behaviors and outline the diagnostic steps to identifying a particular individual’s position on that spectrum.
- Provide an overview of intervening along this spectrum, including attention to SBIRT and medications to assist treatment.
- Describe MI oriented responses to someone with moderate to severe AUD who expresses a desire to decrease rather than stop his or her drinking.
- Outline current evidence related to clinical approaches to “moderation management” including the potential role of medications.
- Psychosocial Support 1
- Understand reactions to the COVID-19 pandemic in light of the Disaster Response Phases timeline.
- Recognize the signs of Critical Incident Stress.
- Understand risk factors for developing PTSD and other post-disaster pathologies.
- Identify strategies to promote resilience and positive coping (for patients and ourselves).
- Vaping 1
- Understand vaping and how it differs from smoking tobacco.
- Understand the scope of the vaping problem.
- Understand teenage use –through stories from our schools.
- Understand vaping related illness – what is known and unknown.
- Understand treatment for tobacco use disorders in teens.
- Be aware of resources.
- Cannabis/CBD for Pain 1
- What do we know about the utility of cannabis products for pain and anxiety?
- What can we learn from states that have increased access about how to use these products clinically?
- How does that need to be adapted in states with limited access or access only to illicit, recreational cannabis?CBD products are available in NC and other states in this region: What do we know about their effectiveness? How can those products be used clinically?
- Hep C and HIV PrEP 1
- Identify patients with risk behaviors for HIV and Hepatitis C infection.
- Describe the necessary work-up required prior to prescribing Hepatitis C treatment and HIV prevention.
- Choose appropriate therapies based on clinical evaluation and patient-specific criteria.
- Design a follow-up plan to optimize patient outcomes.
- Develop a strategy to implement services in the primary care setting.
Learn more about our conferences and educational opportunities
Addiction Medicine Spring and Fall Conferences provide up-to-date substance use related education, applicable across general medical as well as addiction specialty practices.